Europe HBOT Devices Market

Europe HBOT Devices Market Size (2022 to 2027)

The Hyperbaric Oxygen (HBO) Therapy Devices Market in Europe was around USD 46.63 million in 2022. It is expected to grow at a CAGR of 7.3% to reach USD 66.33 million by 2027. It captures 25% of the global market.

Rising per capita income and better government insurance policies are major market drivers for hyperbaric oxygen treatment devices in developed European countries. Furthermore, increasing demand for multiplane HBOT devices for decompression sickness, growing adoption of monoplane HBOT devices for wound healing, rising incidences of gas embolism and carbon monoxide poisoning, and growing investment by key players to develop advanced hyperbaric oxygen therapy devices are expected to propel the market forward.

In addition, as medical tourism grows, the industry is likely to expand. Furthermore, rising obesity and diabetes rates increase the number of stroke occurrences, resulting in increased product demand. Due to the increasing efficacy and multi-functionality of hyperbaric oxygen treatment equipment, the market is expected to expand steadily during the forecast period. The growing use of hyperbaric oxygen treatment in wound healing and aesthetic procedures is likely to fuel demand in the future years. The need for this technology is growing in tandem with many athletes. Increased commercial availability of monoplane systems, increasing demand for monoplane HBOT devices for the convenience of handling, and lower hospital gas supply requirements all contributed to this growth. These factors are predicted to drive the Europe HBOT Devices market during the forecast period.

In Europe, the high cost of therapy and reimbursement issues are inhibiting market expansion to some extent. Furthermore, a small number of medical specialists are wary of HBOT devices being utilized in inappropriate circumstances, limiting their use. Hyperbaric oxygen treatment problems, including seizures, low blood sugar, and short-term nearsightedness, are also likely to have a negative impact on market growth. Furthermore, a lack of understanding of such technology could be a stumbling hurdle to the market's growth. Another market constraint is the potential of medication-related side effects. Among them include changes in vision, sinus damage, oxygen toxicity, and other problems. The increased number of middle ear injuries and eardrum rupture induced by variations in air pressure would limit the market for hyperbaric oxygen therapy equipment.

This research report on the European HBOT devices market has been segmented and sub-segmented into the following categories.

By Product:

• Monoplace HBOT Devices
• Multiplace HBOT Devices  
• Topical HBOT Devices        

By Application

• Wound Healing     
• Decompression Sickness   
• Infection Treatment           
• Gas Embolism        
• Others      

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

In Europe, the number of occurrences of ischemic stroke is on the rise, which is also accelerating the demand for more advanced hyperbaric oxygen therapy equipment in this region. The growth in demand for hyperbaric oxygen therapy equipment is primarily due to an increase in diabetic patients across Europe. As a result, the European market is predicted to rise in the coming years. The market is developing due to the increased incidence and frequency of acute and chronic wounds in Europe, the widespread availability of hyperbaric oxygen treatment equipment, and the rising popularity of leisure and adventure activities.

The UK is predicted to lead Europe's hyperbaric oxygen therapy devices market during the forecast period. The innovation of portable HBOT devices and the growing number of clinical trials supported by various institutions and players show that the market is expanding. The technological improvements are projected to increase demand for hyperbaric oxygen therapy equipment in the coming years.

After the United Kingdom, Germany is expected to have the largest share of the Europe hyperbaric oxygen therapy devices market. The widespread adoption of HBOT technology is one of the primary drivers boosting the market for HBOT devices in Europe.

KEY MARKET PLAYERS:

Companies playing an influential role in the European HBOT devices market include Gulf Coast Hyperbarics, Inc.; Fink Engineering; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); HAUX-LIFE-SUPPORT; HEARMEC; IHC Hytech B.V. (Royal IHC); Hyperbaric SAC; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Europe Ltd.